Literature DB >> 27613481

Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.

An Kang1, Shengjie Zhang2, Dong Zhu3, Yu Dong2, Jinjun Shan4, Tong Xie5, Hongmei Wen3, Liuqing Di6.   

Abstract

Ginsenoside Rb1, an active ingredient in Panax ginseng, was widely used for its various biological activities. To clarify the role of the gut microbiota in pharmacokinetics and metabolism of Rb1, a comprehensive and comparative study of colonic deglycosylation metabolism and systemic exposure of ginsenoside Rb1 in normal rats, antimicrobials (ATMs) treated rats, and restraint stressed rats was conducted. ATMs treated rats received oral administration of non-absorbable antimicrobial mixtures for 7 consecutive days. Restraint stressed rats were subjected to repeated restraint stress for a period of 2 h once daily for 7 days. Plasma concentration dynamics, urine and fecal excretion of Rb1 and its deglycosylation metabolites (Rd, F2, and C-K) were studied. Moreover, the in vitro metabolism of Rb1 in fecal suspension and the fecal β-d-glucosidase activity were profiled. Systemic exposure of the deglycosylation metabolites of ginsenoside Rb1 (F2, C-K) were significantly higher in restraint stressed rats, but ATMs treated rats exhibited a decreased plasma levels of F2 and C-K, compared with normal rats. Further studies illustrated that altered systemic Rb1 and its deglycosylation metabolites exposure in restraint-stressed rats and ATMs treated rats may be partially attributed to alternations in cumulative fecal excretion. The distinguishing fecal β-d-glucosidase, in vitro elimination of Rb1, and formation of these deglycosylation metabolites afforded further evidence for the in vivo data. In conclusion, the dys-regulated fecal β-d-glucosidase activity and deglycosylation metabolism may contribute to the altered pharmacokinetic of ginsenoside Rb1 and its hydrolysis metabolites after ATMs treatment or restraint stress exposure. Our results may offer valuable insights into the pharmacological changes of bioactive ginsenosides in dys-regulated gut microbiota statue.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobials treatment; Deglycosylation metabolism; Ginsenoside Rb(1); Microbiota; Pharmacokinetics; Restraint stress

Mesh:

Substances:

Year:  2016        PMID: 27613481     DOI: 10.1016/j.cbi.2016.09.005

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  Ginsenoside Rb1 Improves Metabolic Disorder in High-Fat Diet-Induced Obese Mice Associated With Modulation of Gut Microbiota.

Authors:  Hong Zou; Man Zhang; Xiaoting Zhu; Liyan Zhu; Shuo Chen; Mingjing Luo; Qinglian Xie; Yue Chen; Kangxi Zhang; Qingyun Bu; Yuchen Wei; Tao Ye; Qiang Li; Xing Yan; Zhihua Zhou; Chen Yang; Yu Li; Haokui Zhou; Chenhong Zhang; Xiaoyan You; Guangyong Zheng; Guoping Zhao
Journal:  Front Microbiol       Date:  2022-04-19       Impact factor: 6.064

2.  Effects of ginsenoside Rb1 on spinal cord ischemia-reperfusion injury in rats.

Authors:  Jin-Tao Ye; Feng-Tao Li; Sheng-Li Huang; Jian-Li Xue; Yirixiati Aihaiti; Hao Wu; Ruo-Xi Liu; Bin Cheng
Journal:  J Orthop Surg Res       Date:  2019-08-14       Impact factor: 2.359

Review 3.  A review for discovering bioactive minor saponins and biotransformative metabolites in Panax quinquefolius L.

Authors:  Zhiyou Yang; Jiahang Deng; Mingxin Liu; Chuantong He; Xinyue Feng; Shucheng Liu; Shuai Wei
Journal:  Front Pharmacol       Date:  2022-08-01       Impact factor: 5.988

4.  Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings.

Authors:  Min-Koo Choi; Sojeong Jin; Ji-Hyeon Jeon; Woo Youl Kang; Sook Jin Seong; Young-Ran Yoon; Yong-Hae Han; Im-Sook Song
Journal:  J Ginseng Res       Date:  2018-10-27       Impact factor: 6.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.